Leuprolide Completed Phase 2 Trials for Endometriosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01767090A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain
NCT00797225Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis
NCT02807363A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers
NCT02203331Bay98-7196, Dose Finding / POC Study
NCT01458301Efficacy and Safety of TAK-385 in the Treatment of Endometriosis
NCT01452685A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis